Multicenter experience with valve ‐in‐valve transcatheter aortic valve replacement compared with primary, native valve transcatheter aortic valve replacement

ConclusionCompared to native TAVR, ViV TAVR has similar peri-procedural morbidity with relatively high postprocedure mean gradients. A multidisciplinary approach will help ensure patients receive the ideal therapy in the setting of structural bioprosthetic valve degeneration.

https://onlinelibrary.wiley.com/doi/10.1111/jocs.17084?af=R

Source: Journal of Cardiac Surgery - November 30, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Michael P. Robich, Alexander Iribarne, David Butzel, Anthony W. DiScipio, Harold L. Dauerman, Bruce J. Leavitt, Joseph P. DeSimone, Megan Coylewright, James M. Flynn, Benjamin M. Westbrook, Peter N. Ver Lee, Mina Zaky, Reed Quinn, David J. Ma Tags: ORIGINAL ARTICLE Source Type: research